Literature DB >> 9490277

Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception.

P L Hermonat1, S Kechelava, C L Lowery, S Korourian.   

Abstract

In a recent study it has been shown that human papillomavirus (HPV) infection was threefold more prevalent in spontaneous abortion specimens compared with elective specimens (60% [15 of 25] v 20% [3 of 15], respectively) as analyzed by broad-spectrum HPV polymerase chain reaction (PCR) amplification and dot-blot hybridization with an HPV-16 probe. In this study, archival paraffin-embedded tissue from a subset of previously analyzed spontaneous abortion cases were reanalyzed by in situ PCR amplification so that the specific cells infected by HPV could be identified. In the current study, using a new PCR primer set for HPV-16 E6, the status of six previously analyzed cases were verified (five HPV-positive and one negative). Furthermore, syncytiotrophoblasts were identified as the predominant cellular target of HPV (HPV-16 or a related type). Finally, four of four third-trimester placentas similarly analyzed gave no HPV-positive signal. Trophoblasts are the cell type that maintains placental contact with maternal tissue and through which nutrient exchange occurs. This knowledge prompts the hypothesis that HPV-infected trophoblasts may have altered characteristics, which may lead to a compromised gestation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490277     DOI: 10.1016/s0046-8177(98)90228-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Human papilloma virus DNA exposure and embryo survival is stage-specific.

Authors:  Andrew A Henneberg; William C Patton; John D Jacobson; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2006-07-27       Impact factor: 3.412

2.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Human papillomavirus vaccine and pregnancy.

Authors:  Andrea Narducci; Adrienne Einarson; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-03       Impact factor: 3.275

4.  A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications.

Authors:  Tania L Slatter; Natalie Gly Hung; William M Clow; Janice A Royds; Celia J Devenish; Noelyn A Hung
Journal:  Mod Pathol       Date:  2015-08-21       Impact factor: 7.842

Review 5.  Genital warts in children: what do they mean?

Authors:  Y Jayasinghe; S M Garland
Journal:  Arch Dis Child       Date:  2006-05-02       Impact factor: 3.791

6.  New insights into the relationship between viral infection and pregnancy complications.

Authors:  Ja-Young Kwon; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-04-07       Impact factor: 3.886

7.  Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors.

Authors:  Sante Roperto; Giuseppe Borzacchiello; Iolanda Esposito; Marita Riccardi; Chiara Urraro; Roberta Lucà; Annunziata Corteggio; Rosarita Tatè; Michele Cermola; Orlando Paciello; Franco Roperto
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

8.  Transplacental transmission of Human Papillomavirus.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2008-09-25       Impact factor: 4.099

9.  Molecular Epidemiology of High-Risk Types of Human Papillomaviruses (16, 18) in Pap-Smear, the North East of Iran.

Authors:  A Moradi; S Bakhshandeh Nosrat; S Besharat
Journal:  Iran J Cancer Prev       Date:  2011

10.  HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells.

Authors:  Lea M M Ambühl; Annemarie B Villadsen; Ulrik Baandrup; Karen Dybkær; Suzette Sørensen
Journal:  Pathogens       Date:  2017-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.